Abstract
Molecular genetic studies of the effects of rare, pathogenic mutations have provided deep insights into mechanisms of causation for all forms of autism spectrum disorder (ASD) and highlight a new opportunity to specify treatment, prognosis, family recurrence risk, and the prospective management of common “comorbidities” that exacerbate the severity of impairment in ASD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
